Tirzepatide vs. Warfarin
Compare Tirzepatide and Warfarin: mechanism of action, indications, side effects, cost, and which may be right for you.
Quick Comparison
| Category | Tirzepatide | Warfarin |
|---|---|---|
| Drug Class | GLP-1 Receptor Agonists | Anticoagulants |
| Rx Status | Rx | Rx |
| Generic Available | No | No |
| Typical Cost | $299–$1,112/month | $10–$30/month |
Tirzepatide Overview
Tirzepatide is a once-weekly injectable prescription medication that activates both the GIP and GLP-1 hormone receptors — making it the first dual GIP/GLP-1 receptor agonist approved by the FDA. It is sold as Mounjaro for type 2 diabetes and as Zepbound for chronic weight management and obstructive sleep apnea. Clinical trials show it reduces HbA1c by up to 2.58 percentage points and body weight b...
Full Tirzepatide guide →Warfarin Overview
Warfarin is a "blood thinner" (anticoagulant) medication that helps prevent harmful blood clots from forming or growing larger in your body. It is prescribed to reduce the risk of serious problems like strokes, heart attacks, and clots in the legs or lungs, especially for people with certain heart conditions or after a heart attack.
Full Warfarin guide →How Each Drug Works
Tirzepatide
Tirzepatide is a dual GIP/GLP-1 receptor agonist — the first in its class. It is a 39-amino acid synthetic peptide with a C20 fatty diacid moiety attached via a linker, which enables albumin binding and extends the plasma half-life to approximately 5 days, supporting once-weekly dosing.
GLP-1 receptor activation produces:
- Glucose-dependent stimulation of insulin secretion (first and second phase)
- Suppression of glucagon secretion in a glucose-dependent manner
- Slowing of gastric em…
Approved Uses (Indications)
Tirzepatide
Mounjaro (tirzepatide) is FDA-approved as an adjunct to diet and exercise to improve glycemic control in:
- Adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus
Zepbound (tirzepatide) is FDA-approved for:
- Chronic weight management in adults with initial BMI ≥30 kg/m² (obesity), or ≥27 kg/m² (overweight) with at least one weight-related comorbidity (hypertension, dyslipidemia, type 2 diabetes, obstructive sleep apnea, or cardiovascular disease), used as an adjunct to a reduced-calorie diet and increased physical activity
- **Moderate-to-severe o…
Warfarin
Warfarin sodium tablets are indicated for: Prophylaxis and treatment of venous thrombosis and its extension, pulmonary embolism (PE). Prophylaxis and treatment of thromboembolic complications associated with atrial fibrillation (AF) and/or cardiac valve replacement. Reduction in the risk of death, recurrent myocardial infarction (MI), and thromboembolic events such as stroke or systemic embolization after myocardial infarction. Limitations of Use Warfarin sodium tablets have no direct effect on an established thrombus, nor does it reverse ischemic tissue damage. Once a …
Side Effects
Tirzepatide
Serious Side Effects
Common Side Effects
Rare Side Effects
Warfarin
Cost Comparison
Tirzepatide
$299–$1,112/month
Tirzepatide is available under two brand names with different pricing structures: **Mounjaro (diabetes indication):** - List price: approximately $1,086–$1,112 per 4-week supply (all doses) - With commercial insurance savings card: as low as $25/month for eligible patients - Medicare Part D: covered for type 2 diabetes; prior authorization typically required **Zepbound (weight management indication):** - Autoinjector pen list price: approximately $1,086/month - Single-dose vials (2.5 mg, 5 mg) via LillyDirect: $299–$549/month — the most affordable option for patients paying out of pocket - With commercial insurance savings card: as low as $25/month - Medicare Part D: does not cover Zepbound for weight loss; covers for OSA indication starting April 2026 at ~$50/month copay No FDA-approved generic tirzepatide exists as of 2026. Compounded tirzepatide is no longer permitted under the shortage exemption following the FDA's declaration that the shortage has been resolved.
Warfarin
$10–$30/month
Warfarin is available as a generic and is generally very affordable. Using discount cards like GoodRx can often reduce the cost further, even without insurance.
Drug Interaction: Moderate
Tirzepatide can delay gastric emptying, which may affect the absorption rate and extent of orally administered medications like warfarin. While no specific interaction study with warfarin has been conducted, this potential change in absorption could theoretically alter warfarin's anticoagulant effect, increasing the risk of bleeding or thrombosis.
Mechanism: Tirzepatide, as a GLP-1/GIP receptor agonist, slows gastric emptying. This delayed transit through the gastrointestinal tract could lead to altered absorption kinetics of concurrently administered oral medications, potentially affecting the time to peak concentration (Tmax) and overall exposure (AUC) of warfarin.
Compare prices for Tirzepatide and Warfarin
Check real-time pharmacy prices before you fill — free, no account needed.
Protect your muscle mass on GLP-1 medications
GLP-1 medications can cause up to 39% muscle loss alongside fat. Zova's AI-powered protocol — backed by Lancet Diabetes & Endocrinology research — reduces that to just 8.7% through leucine tracking and injection-day adaptive nutrition.
No credit card. No commitment.
Medical Disclaimer
The information on RxGuide is intended for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician, pharmacist, or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.